{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CYP3A1", "cardiovascular system drugs", "high-altitude hypoxia", "pharmacokinetics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36297415", "DateRevised": {"Year": "2022", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "21"}], "Language": ["eng"], "ELocationID": ["1303", "10.3390/ph15101303"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "15", "Issue": "10", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "21"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "High-altitude Hypoxia Influences the Activities of the Drug-Metabolizing Enzyme CYP3A1 and the Pharmacokinetics of Four Cardiovascular System Drugs.", "Abstract": {"AbstractText": ["(1) Background: High-altitude hypoxia has been shown to affect the pharmacokinetic properties of drugs. Although there is a high incidence of cardiovascular disease among individuals living in high-altitude areas, studies on the effect of high-altitude hypoxia on the pharmacokinetic properties of cardiovascular drugs are limited. (2) Methods: The aim of this study was to evaluate the pharmacokinetics of nifedipine, bosentan, simvastatin, sildenafil, and their respective main metabolites, dehydronifedipine, hydroxybosentan, simvastatin hydroxy acid, and N-desmethyl sildenafil, in rats exposed to high-altitude hypoxia. Additionally, the protein and mRNA expression of cytochrome P450 3A1 (CYP3A1), a drug-metabolizing enzyme, were examined. (3) Results: There were significant changes in the pharmacokinetic properties of the drugs in rats exposed to high-altitude hypoxia, as evidenced by an increase in the area under the curve (AUC) and the half-life (t<sub>1/2z</sub>) and a decrease in total plasma clearance (CL<sub>z</sub>/F). However, most of these changes were reversed when the rats returned to a normoxic environment. Additionally, there was a significant decrease in CYP3A1 expression in rats exposed to high-altitude hypoxia at both the protein and mRNA levels. (4) Conclusions: High-altitude hypoxia suppressed the metabolism of the drugs, indicating that the pharmacokinetics of the drugs should be re-examined, and the optimal dose should be reassessed in patients living in high-altitude areas."]}, "AuthorList": [{"Identifier": ["0000-0002-3786-6727"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University Medical College, Xining 810000, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining 810000, China."}], "LastName": "Zhu", "ForeName": "Junbo", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Qinghai University Affiliated Hospital, Xining 810000, China."}], "LastName": "Duan", "ForeName": "Yabin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University Medical College, Xining 810000, China."}], "LastName": "Duo", "ForeName": "Delong", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University Medical College, Xining 810000, China."}], "LastName": "Yang", "ForeName": "Jianxin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University Medical College, Xining 810000, China."}], "LastName": "Bai", "ForeName": "Xue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University Medical College, Xining 810000, China."}], "LastName": "Liu", "ForeName": "Guiqin", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University Medical College, Xining 810000, China."}], "LastName": "Wang", "ForeName": "Qian", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anesthesiology, Red Cross Hospital of Qinghai, Xining 810000, China."}], "LastName": "Wang", "ForeName": "Xuejun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anesthesiology, Qinghai Hospital of Traditional Chinese Medicine, Xining 810000, China."}], "LastName": "Qu", "ForeName": "Ning", "Initials": "N"}, {"Identifier": ["0000-0003-0556-7228"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Zhou", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": ["0000-0001-6494-2388"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University Medical College, Xining 810000, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining 810000, China."}], "LastName": "Li", "ForeName": "Xiangyang", "Initials": "X"}], "GrantList": [{"GrantID": "No. 2021-ZJ-T03", "Agency": "Qinghai innovation platform construction project, China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li J., He N., Wei X., Gao Y., Zuo Y. Changes in Temperature Sensitivity and Activation Energy of Soil Organic Matter Decomposition in Different Qinghai-Tibet Plateau Grasslands. PLoS ONE. 2015;10:e0132795. doi: 10.1371/journal.pone.0132795.", "ArticleIdList": ["10.1371/journal.pone.0132795", "PMC4503348", "26176705"]}, {"Citation": "Eide 3rd R.P., Asplund C.A. Altitude Illness: Update on Prevention and Treatment. Curr. Sport. Med. Rep. 2012;11:124\u2013130. doi: 10.1249/JSR.0b013e3182563e7a.", "ArticleIdList": ["10.1249/JSR.0b013e3182563e7a", "22580489"]}, {"Citation": "Jiang C., Chen J., Liu F., Luo Y., Xu G., Shen H.-Y., Gao W. Chronic mountain sickness in Chinese Han males who migrated to the Qinghai-Tibetan plateau: Application and evaluation of diagnostic criteria for chronic mountain sickness. BMC Public Health. 2014;14 doi: 10.1186/1471-2458-14-701.", "ArticleIdList": ["10.1186/1471-2458-14-701", "PMC4227059", "25007716"]}, {"Citation": "Manferdelli G., Marzorati M., Easton C., Porcelli S. Changes in prefrontal cerebral oxygenation and microvascular blood volume in hypoxia and possible association with acute mountain sickness. Exp. Physiol. 2021;106:76\u201385. doi: 10.1113/EP088515.", "ArticleIdList": ["10.1113/EP088515", "32715540"]}, {"Citation": "Narvaez-Guerra O., Herrera-Enriquez K., Medina-Lezama J., Chirinos J.A. Systemic Hypertension at High Altitude. Hypertension. 2018;72:567\u2013578. doi: 10.1161/HYPERTENSIONAHA.118.11140.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.118.11140", "PMC6205208", "30354760"]}, {"Citation": "Shen Y., Chang C., Zhang J., Jiang Y., Ni B., Wang Y. Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: A cross-sectional study. Environ. Health Prev. Med. 2017;22 doi: 10.1186/s12199-017-0634-7.", "ArticleIdList": ["10.1186/s12199-017-0634-7", "PMC5664790", "29165123"]}, {"Citation": "Mingji C., Onakpoya I.J., Perera R., Ward A.M., Heneghan C.J. Relationship between altitude and the prevalence of hypertension in Tibet: A systematic review. Heart. 2015;101:1054\u20131060. doi: 10.1136/heartjnl-2014-307158.", "ArticleIdList": ["10.1136/heartjnl-2014-307158", "PMC4484261", "25953970"]}, {"Citation": "Yue L., Fan Z., Sun L., Feng W., Li J. Prevalence of Essential Hypertension and Its Complications Among Chinese Population at High Altitude. High Alt. Med. Biol. 2017;18:140\u2013144. doi: 10.1089/ham.2016.0078.", "ArticleIdList": ["10.1089/ham.2016.0078", "28632449"]}, {"Citation": "Ma L., Chen Q., Wang Y., Wang J., Ren Z., Cao Z., Wang B. Spatial pattern and variations in the prevalence of congenital heart disease in children aged 4\u201318 years in the Qinghai-Tibetan Plateau. Sci. Total Environ. 2018;627:158\u2013165. doi: 10.1016/j.scitotenv.2018.01.194.", "ArticleIdList": ["10.1016/j.scitotenv.2018.01.194", "29426137"]}, {"Citation": "Sergi C. EPAS1, Congenital heart disease, and high altitude: Disclosures by genetics, bioinformatics, and experimental embryology. Biosci. Rep. 2019;39 doi: 10.1042/BSR20182197.", "ArticleIdList": ["10.1042/BSR20182197", "PMC6509053", "31015364"]}, {"Citation": "El-Sherif N., Turitto G., Boutjdir M. Congenital Long QT syndrome and torsade de pointes. Ann. Noninvasive Electrocardiol. 2017;22:e12481. doi: 10.1111/anec.12481.", "ArticleIdList": ["10.1111/anec.12481", "PMC6931590", "28670758"]}, {"Citation": "Yang J., Liu C., Jihang Z., Yu J., Dai L., Ding X., Huang L. PPARA genetic variants increase the risk for cardiac pumping function reductions following acute high-altitude exposure: A self-controlled study. Mol. Genet. Genom. Med. 2019;7:e00919. doi: 10.1002/mgg3.919.", "ArticleIdList": ["10.1002/mgg3.919", "PMC6785441", "31407515"]}, {"Citation": "Bhattarai P., Paudel B.H., Thakur D., Bhattarai B., Subedi B., Khadka R. Effect of long term high altitude exposure on cardiovascular autonomic adjustment during rest and post-exercise recovery. Ann. Occup. Environ. Med. 2018;30 doi: 10.1186/s40557-018-0240-1.", "ArticleIdList": ["10.1186/s40557-018-0240-1", "PMC5948791", "29780604"]}, {"Citation": "Zhou X., Nian Y., Qiao Y., Yang M., Xin Y., Li X. Hypoxia plays a key role in the pharmacokinetic changes of drugs at high altitude. Curr. Drug Metab. 2018;19:960\u2013969. doi: 10.2174/1389200219666180529112913.", "ArticleIdList": ["10.2174/1389200219666180529112913", "29807512"]}, {"Citation": "Vij A.G., Kishore K., Dey J. Effect of intermittent hypobaric hypoxia on efficacy & clearance of drugs. Indian J. Med. Res. 2012;135:211.", "ArticleIdList": ["PMC3336852", "22446863"]}, {"Citation": "Arancibia A., Gai M.N., Ch\u00e1vez J., Paulos C., Pinilla E., Gonz\u00e1lez C., Ritschel W.A. Pharmacokinetics of prednisolone in man during acute and chronic exposure to high altitude. Int. J. Clin. Pharmacol. Ther. 2005;43:85\u201391. doi: 10.5414/CPP43085.", "ArticleIdList": ["10.5414/CPP43085", "15726877"]}, {"Citation": "Wei L., Li L., Zhang B., Ma L. Propranolol Suppresses Cobalt Chloride-Induced Hypoxic Proliferation in Human Umbilical Vein Endothelial Cells in vitro. Pharmacology. 2019;103:61\u201367. doi: 10.1159/000494762.", "ArticleIdList": ["10.1159/000494762", "30448832"]}, {"Citation": "Schroeder T., Piantadosi C.A., Natoli M.J., Autmizguine J., Cohen-Wolkowieczs M., Hamilton K.L., Noveck R.J. Safety and ergogenic properties of combined aminophylline and ambrisentan in hypoxia. Clin. Pharmacol. 2018;103:888\u2013898. doi: 10.1002/cpt.860.", "ArticleIdList": ["10.1002/cpt.860", "PMC5947522", "28857147"]}, {"Citation": "Tapia L., Irarr\u00e1zaval S. Acetazolamide for the treatment of acute mountain sickness. Medwave. 2019;19:e7737. doi: 10.5867/medwave.2019.11.7736.", "ArticleIdList": ["10.5867/medwave.2019.11.7736", "31891352"]}, {"Citation": "Li X., Gao F., Li Z., Guan W., Feng W., Ge R. Comparison of the pharmacokinetics of sulfamethoxazole in male chinese volunteers at low altitude and acute exposure to high altitude versus subjects living chronically at high altitude: An open-label, controlled, prospective study. Clin. Ther. 2009;31:2744\u20132754. doi: 10.1016/j.clinthera.2009.11.019.", "ArticleIdList": ["10.1016/j.clinthera.2009.11.019", "20110016"]}, {"Citation": "Zhou Y., Wen J., Wang G. Identification of cytochrome P450 isoenzymes involved in the metabolism of 23-hydroxybetulinic acid in human liver microsomes. Pharm. Biol. 2019;58:60\u201363. doi: 10.1080/13880209.2019.1701500.", "ArticleIdList": ["10.1080/13880209.2019.1701500", "PMC6968681", "31868554"]}, {"Citation": "Manikandan P., Nagini S. Cytochrome P450 Structure, Function and Clinical Significance: A Review. Curr. Drug Targets. 2018;19:38\u201354. doi: 10.2174/1389450118666170125144557.", "ArticleIdList": ["10.2174/1389450118666170125144557", "28124606"]}, {"Citation": "Guengerich F.P. Cytochrome P450 research and the journal of biological chemistry. J. Biol. Chem. 2019;294:1671\u20131680. doi: 10.1074/jbc.TM118.004144.", "ArticleIdList": ["10.1074/jbc.TM118.004144", "PMC6364786", "29871932"]}, {"Citation": "Tornio A., Backman J.T. Cytochrome P450 in pharmacogenetics: An update. Adv. Pharmacol. 2018;83:3\u201332. doi: 10.1016/bs.apha.2018.04.007.", "ArticleIdList": ["10.1016/bs.apha.2018.04.007", "29801580"]}, {"Citation": "Guengerich F.P., Waterman M.R., Egli M. Recent Structural Insights into Cytochrome P450 Function. Trends Pharmacol. Sci. 2016;37:625\u2013640. doi: 10.1016/j.tips.2016.05.006.", "ArticleIdList": ["10.1016/j.tips.2016.05.006", "PMC4961565", "27267697"]}, {"Citation": "Kato H. Computational prediction of cytochrome P450 inhibition and induction. Drug Metab. Pharmacokinet. 2019;35:30\u201344. doi: 10.1016/j.dmpk.2019.11.006.", "ArticleIdList": ["10.1016/j.dmpk.2019.11.006", "31902468"]}, {"Citation": "Park J.W., Choi J.S. Role of kaempferol to increase bioavailability and pharmacokinetics of nifedipine in rats. Chin. J. Nat. Med. 2019;17:690\u2013697. doi: 10.1016/S1875-5364(19)30083-4.", "ArticleIdList": ["10.1016/S1875-5364(19)30083-4", "31526504"]}, {"Citation": "Tubic-Grozdanis M., Hilfinger J.M., Amidon G.L., Kim J.S., Kijek P., Staubach P., Langguth P. Pharmacokinetics of the CYP 3A Substrate Simvastatin following Administration of Delayed Versus Immediate Release Oral Dosage Forms. Pharm. Res. 2008;25:1591\u20131600. doi: 10.1007/s11095-007-9519-6.", "ArticleIdList": ["10.1007/s11095-007-9519-6", "18213452"]}, {"Citation": "Gillen M., Yang C., Wilson D., Valdez S., Lee C., Kerr B., Shen Z. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and CYP Enzyme Substrates Sildenafil, Amlodipine, Tolbutamide, and Repaglinide. Clin. Pharmacol. Drug Dev. 2017;6:363\u2013376. doi: 10.1002/cpdd.324.", "ArticleIdList": ["10.1002/cpdd.324", "28067999"]}, {"Citation": "Hyland R., Roe E.G.H., Jones B.C., Smith D.A. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br. J. Clin. Pharmacol. 2008;51:239\u2013248. doi: 10.1046/j.1365-2125.2001.00318.x.", "ArticleIdList": ["10.1046/j.1365-2125.2001.00318.x", "PMC2015027", "11298070"]}, {"Citation": "Chen M., Zhang X., Chen Y., Sun W., Wang Z., Huang C., Chen R. Comparison of the Inhibitory Effect of Ketoconazole, Voriconazole, Fluconazole, and Itraconazole on the Pharmacokinetics of Bosentan and Its Corresponding Active Metabolite Hydroxy Bosentan in Rats. Xenobiotica. 2019;50:280\u2013287. doi: 10.1080/00498254.2019.1628321.", "ArticleIdList": ["10.1080/00498254.2019.1628321", "31199171"]}, {"Citation": "Li X., Wang X., Li Y., Yuan M., Zhu J., Su X., Duan Y. Effect of Exposure to Acute and Chronic High-Altitude Hypoxia on the Activity and Expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 and NAT2 in Rats. Pharmacology. 2014;93:76\u201383. doi: 10.1159/000358128.", "ArticleIdList": ["10.1159/000358128", "24557547"]}, {"Citation": "Li X., Wang X., Li Y., Zhu J., Su X., Yao X., Duan Y. The Activity, Protein, and mRNA Expression of CYP2E1 and CYP3A1 in Rats after Exposure to Acute and Chronic High Altitude Hypoxia. High Alt. Med. Biol. 2014;15:491\u2013496. doi: 10.1089/ham.2014.1026.", "ArticleIdList": ["10.1089/ham.2014.1026", "25330250"]}, {"Citation": "Xia Y., Xia L., Jin Z., Jin R., Paudel O., Sham J.S.K. Cytochrome P450 Epoxygenase-Dependent Activation of TRPV4 Channel Participates in Enhanced Serotonin-Induced Pulmonary Vasoconstriction in Chronic Hypoxic Pulmonary Hypertension. Anal. Cell. Pathol. 2020;2020:8927381. doi: 10.1155/2020/8927381.", "ArticleIdList": ["10.1155/2020/8927381", "PMC7204149", "32399392"]}, {"Citation": "Kurdi J., Maurice H., El-Kadi A.O.S., Ong H., Dalkara S., B\u00e9langer P.M., du Souich P. Effect of hypoxia alone or combined with inflammation and 3-methylcholanthrene on hepatic cytochrome P450 in conscious rabbits. Br. J. Pharmacol. 1999;128:365\u2013373. doi: 10.1038/sj.bjp.0702795.", "ArticleIdList": ["10.1038/sj.bjp.0702795", "PMC1571639", "10510446"]}, {"Citation": "Zhang X., Zeng Y., Chen X., Zhang Y., Ding J., Xue C. Decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model. J. Thorac. Dis. 2018;10:825. doi: 10.21037/jtd.2017.12.106.", "ArticleIdList": ["10.21037/jtd.2017.12.106", "PMC5864663", "29607154"]}, {"Citation": "Yu H., Shao H., Wu Q., Sun X., Li L., Li K., Chen H. Altered gene expression of hepatic cytochrome P450 in a rat model of intermittent hypoxia with emphysema. Mol. Med. Rep. 2017;16:881\u2013886. doi: 10.3892/mmr.2017.6642.", "ArticleIdList": ["10.3892/mmr.2017.6642", "28560400"]}, {"Citation": "Kwapiszewska G., Johansen A.K.Z., Gomez-Arroyo J., Voelkel N.F. The Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases. Circ. Res. 2019;125:356\u2013366. doi: 10.1161/CIRCRESAHA.119.315054.", "ArticleIdList": ["10.1161/CIRCRESAHA.119.315054", "31242807"]}, {"Citation": "Zhou Q., Ruan Z.R., Jiang B., Yuan H., Zeng S. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms. Pharmazie. 2013;68:124\u2013128. doi: 10.1691/ph.2013.2676.", "ArticleIdList": ["10.1691/ph.2013.2676", "23469684"]}, {"Citation": "Humbert M., Simonneau G. Sildenafil for Pulmonary Arterial Hypertension. Am. J. Respir. Crit. Care Med. 2004;169:6\u20137. doi: 10.1164/rccm.2310007.", "ArticleIdList": ["10.1164/rccm.2310007", "14695103"]}, {"Citation": "Abdelkawy K.S., Donia A.M., Turner R.B., Elbarbry F. Effects of lemon and Seville orange juices on the pharmacokinetic properties of sildenafil in healthy subjects. Drugs RD. 2016;16:271\u2013278. doi: 10.1007/s40268-016-0140-1.", "ArticleIdList": ["10.1007/s40268-016-0140-1", "PMC5045831", "27550653"]}, {"Citation": "Srinivas N.R. Clinical drug-drug interactions of bosentan, a potent endothelial receptor antagonist, with various drugs: Physiological role of enzymes and transporters. Gen. Physiol. Biophys. 2016;35:243\u2013258. doi: 10.4149/gpb_2015050.", "ArticleIdList": ["10.4149/gpb_2015050", "27045668"]}, {"Citation": "Zhu J., Yang J., Nian Y., Liu G., Duan Y., Bai X., Li X. Pharmacokinetics of acetaminophen and metformin hydrochloride in rats after exposure to simulated high altitude hypoxia. Front. Pharmacol. 2021;12:692349. doi: 10.3389/fphar.2021.692349.", "ArticleIdList": ["10.3389/fphar.2021.692349", "PMC8249799", "34220516"]}, {"Citation": "Sarada S.K., Dipti P., Anju B., Pauline T., Kain A., Sairam M., Selvamurthy W. Antioxidant effect of beta-carotene on hypoxia induced oxidative stress in male albino rats. J. Ethnopharmacol. 2002;79:149\u2013153. doi: 10.1016/S0378-8741(01)00360-9.", "ArticleIdList": ["10.1016/S0378-8741(01)00360-9", "11801375"]}, {"Citation": "Schoutsen B., De Jong J.W., Harmsen E., De Tombe P.P., Achterberg P.W. Myocardial xanthine oxidase/ dehydrogenase. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1983;762:519\u2013524. doi: 10.1016/0167-4889(83)90055-1.", "ArticleIdList": ["10.1016/0167-4889(83)90055-1", "6575831"]}, {"Citation": "Nepal O., Pokharel B., Khanal K., Mallik S., Kapoor B., Koju R. Relationship Between Arterial Oxygen Saturation and Hematocrit, and Effect of Slow Deep Breathing on Oxygen Saturation in Himalayan High Altitude Populations. Kathmandu Univ. Med. J. 2013;10:30\u201334. doi: 10.3126/kumj.v10i3.8014.", "ArticleIdList": ["10.3126/kumj.v10i3.8014", "23434958"]}, {"Citation": "Paterson G.G., Young J.M., Willson J.A., Graham C.J., Dru R.C., Lee E.W., Thompson A.A.R. Hypoxia Modulates Platelet Purinergic Signalling Pathways. Thromb. Haemost. 2019;120:253\u2013261. doi: 10.1055/s-0039-3400305.", "ArticleIdList": ["10.1055/s-0039-3400305", "PMC7286126", "31858521"]}, {"Citation": "Villafuerte F.C. New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness. J. Appl. Physiol. 2015;119:1481\u20131486. doi: 10.1152/japplphysiol.00271.2015.", "ArticleIdList": ["10.1152/japplphysiol.00271.2015", "PMC4683346", "26272318"]}, {"Citation": "Vij A.G. Effect of prolonged stay at high altitude on platelet aggregation and fibrinogen levels. Platelets. 2009;20:421\u2013427. doi: 10.1080/09537100903116516.", "ArticleIdList": ["10.1080/09537100903116516", "19658003"]}, {"Citation": "Chen S., Du C., Shen M., Zhao G., Xu Y., Yang K., Wang J. Sympathetic stimulation facilitates thrombopoiesis by promoting megakaryocyte adhesion, migration, and proplatelet formation. Blood. 2015;127:1024\u20131035. doi: 10.1182/blood-2015-07-660746.", "ArticleIdList": ["10.1182/blood-2015-07-660746", "26644453"]}, {"Citation": "Zierk J., Arzideh F., Rechenauer T., Haeckel R., Rascher W., Metzler M., Rauh M. Age and Sex-Specific Dynamics in 22 Hematologic and Biochemical Analytes from Birth to Adolescence. Clin. Chem. 2015;61:964\u2013973. doi: 10.1373/clinchem.2015.239731.", "ArticleIdList": ["10.1373/clinchem.2015.239731", "25967371"]}, {"Citation": "Shin M.K., Yao Q., Jun J., Bevans-Fonti S., Yoo D.Y., Han W., Polotsky V.Y. Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxia. J. Appl. Physiol. 2014;117:765\u2013776. doi: 10.1152/japplphysiol.01133.2013.", "ArticleIdList": ["10.1152/japplphysiol.01133.2013", "PMC4187050", "25103977"]}, {"Citation": "Arestegui A.H., Fuquay R., Sirota J., Swenson E.R., Schoene R.B., Jefferson J.A., Escudero E. High Altitude Renal Syndrome (HARS) J. Am. Soc. Nephrol. 2011;22:1963\u20131968. doi: 10.1681/ASN.2010121316.", "ArticleIdList": ["10.1681/ASN.2010121316", "21566053"]}, {"Citation": "Caravita S., Faini A., Bilo G., Revera M., Giuliano A., Gregorini F., Parati G. Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply\u2013demand. Int. J. Cardiol. 2014;171:e100\u2013e102. doi: 10.1016/j.ijcard.2013.12.003.", "ArticleIdList": ["10.1016/j.ijcard.2013.12.003", "24377715"]}, {"Citation": "Mix J., Elon L., Vi Thien Mac V., Flocks J., Economos E., Tovar-Aguilar A.J., McCauley L.A. Hydration Status, Kidney Function, and Kidney Injury in Florida Agricultural Workers. J. Occup. Environ. Med. 2018;60:e253\u2013e260. doi: 10.1097/JOM.0000000000001261.", "ArticleIdList": ["10.1097/JOM.0000000000001261", "29271837"]}, {"Citation": "Plata R., Cornejo A., Arratia C., Anabaya A., Perna A., Dimitrov B.D., Remuzzi G. Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: A prospective randomised trial. Lancet. 2002;359:663\u2013666. doi: 10.1016/S0140-6736(02)07812-1.", "ArticleIdList": ["10.1016/S0140-6736(02)07812-1", "11879862"]}, {"Citation": "Yang C., Ling H., Zhang M., Yang Z., Wang X., Zeng F., Feng J. Oxidative stress mediates chemical hypoxia-induced injury and inflammation by activating NF-\u03bab-COX-2 pathway in HaCaT cells. Mol. Cells. 2011;31:531\u2013538. doi: 10.1007/s10059-011-1025-3.", "ArticleIdList": ["10.1007/s10059-011-1025-3", "PMC3887613", "21533553"]}, {"Citation": "Eichstaedt C.A., Mairb\u00e4url H., Song J., Benjamin N., Fischer C., Dehnert C., Hinderhofer K. Genetic Predisposition to High-Altitude Pulmonary Edema. High Alt. Med. Biol. 2020;21:28\u201336. doi: 10.1089/ham.2019.0083.", "ArticleIdList": ["10.1089/ham.2019.0083", "31976756"]}, {"Citation": "Seys S.F., Daenen M., Dilissen E., Van Thienen R., Bullens D.M.A., Hespel P., Dupont L.J. Effects of high altitude and cold air exposure on airway inflammation in patients with asthma. Thorax. 2013;68:906\u2013913. doi: 10.1136/thoraxjnl-2013-203280.", "ArticleIdList": ["10.1136/thoraxjnl-2013-203280", "23821393"]}, {"Citation": "Preissner S.C., Hoffmann M.F., Preissner R., Dunkel M., Gewiess A., Preissner S. Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy. PLoS ONE. 2013;8:e82562. doi: 10.1371/journal.pone.0082562.", "ArticleIdList": ["10.1371/journal.pone.0082562", "PMC3858335", "24340040"]}, {"Citation": "Sevrioukova I.F., Poulos T.L. Understanding the mechanism of cytochrome P450 3A4: Recent advances and remaining problems. Dalton Trans. 2013;42:3116\u20133126. doi: 10.1039/C2DT31833D.", "ArticleIdList": ["10.1039/C2DT31833D", "PMC3787833", "23018626"]}, {"Citation": "Fradette C., Batonga J., Teng S., Piquette-Miller M., du Souich P. Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver. Drug Metab. Dispos. 2007;35:765\u2013771. doi: 10.1124/dmd.106.013508.", "ArticleIdList": ["10.1124/dmd.106.013508", "17303624"]}, {"Citation": "Fradette C., Souich P.D. Hypoxia-inducible factor-1 and activator protein-1 modulate the upregulation of CYP3A6 induced by hypoxia. Br. J. Pharmacol. 2003;140:1146\u20131154. doi: 10.1038/sj.bjp.0705543.", "ArticleIdList": ["10.1038/sj.bjp.0705543", "PMC1574128", "14559859"]}, {"Citation": "Fradette C., Yamaguchi N., du Souich P. 5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide. Br. J. Pharmacol. 2004;141:407\u2013414. doi: 10.1038/sj.bjp.0705632.", "ArticleIdList": ["10.1038/sj.bjp.0705632", "PMC1574215", "14718257"]}, {"Citation": "Duan Y., Zhu J., Yang J., Gu W., Bai X., Liu G., Xiangyang L. A decade\u2019s review of miRNA: A center of transcriptional regulation of drugmetabolizing enzymes and transporters under hypoxia. Curr. Drug Metab. 2021;22:709\u2013725. doi: 10.2174/1389200222666210514011313.", "ArticleIdList": ["10.2174/1389200222666210514011313", "33992050"]}, {"Citation": "Legendre C., Hori T., Loyer P., Aninat C., Ishida S., Glaise D., Morel F. Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1\u03b1 involvement in CYP3A4 repression. Eur. J. Cancer. 2009;45:2882\u20132892. doi: 10.1016/j.ejca.2009.07.010.", "ArticleIdList": ["10.1016/j.ejca.2009.07.010", "19695866"]}, {"Citation": "Duan Y., Zhu J., Yang J., Liu G., Bai X., Qu N., Li X. Regulation of High-Altitude Hypoxia on the Transcription of CYP450 and UGT1A1 Mediated by PXR and CAR. Front. Pharmacol. 2020;11 doi: 10.3389/fphar.2020.574176.", "ArticleIdList": ["10.3389/fphar.2020.574176", "PMC7527593", "33041817"]}, {"Citation": "Duan Y., Bai X., Yang J., Zhou Y., Gu W., Liu G., Li X. Exposure to High-Altitude Environment Is Associated with Drug Transporters Change: microRNA-873-5p-Mediated Alteration of Function and Expression Levels of Drug Transporters under Hypoxia. Drug Metab. Dispos. 2022;50:174\u2013186. doi: 10.1124/dmd.121.000681.", "ArticleIdList": ["10.1124/dmd.121.000681", "34844996"]}, {"Citation": "Li H., He J., Jia W. The influence of gut microbiota on drug metabolism and toxicity. Expert Opin. Drug Metab. Toxicol. 2015;12:31\u201340. doi: 10.1517/17425255.2016.1121234.", "ArticleIdList": ["10.1517/17425255.2016.1121234", "PMC5683181", "26569070"]}, {"Citation": "Zhang J., Zhang J., Wang R., Jia Z. Effects of gut microbiota on drug metabolism and guidance for rational drug use under hypoxic conditions at high altitudes. Curr. Drug Metab. 2019;20:155\u2013165. doi: 10.2174/1389200219666181019145159.", "ArticleIdList": ["10.2174/1389200219666181019145159", "30338735"]}, {"Citation": "Zhang J., Chen Y., Sun Y., Wang R., Zhang J., Jia Z. Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine. Drug Deliv. 2018;25:1175\u20131181. doi: 10.1080/10717544.2018.1469687.", "ArticleIdList": ["10.1080/10717544.2018.1469687", "PMC6058681", "29790376"]}, {"Citation": "Liu G., Bai X., Duan Y., Zhu J., Yang J., Wang Q., Li X. Changes in the intestinal flora of rats under high altitude hypoxia. Acta Pharm. Sin. 2021;56:1100\u20131108. doi: 10.16438/j.0513-4870.2020-1628.", "ArticleIdList": ["10.16438/j.0513-4870.2020-1628"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "16"}, {"Year": "2022", "Month": "10", "Day": "11"}, {"Year": "2022", "Month": "10", "Day": "18"}, {"Year": "2022", "Month": "10", "Day": "27", "Hour": "1", "Minute": "50"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["36297415", "PMC9612038", "10.3390/ph15101303", "ph15101303"]}}], "PubmedBookArticle": []}